RTW

RTW Biotech Opportunities portfolio company Penumbra to be acquired by Boston Scientific

RTW Biotech Opportunities Ltd announces that Boston Scientific Corporation has agreed to acquire Penumbra, Inc., a public portfolio company, in a transaction valued at $14.5 billion...
Search

Funds

May 10, 2024

RTW Biotech Opportunities portfolio company Penumbra to be acquired by Boston Scientific

RTW Biotech Opportunities Ltd announces that Boston Scientific Corporation has agreed to acquire Penumbra, Inc., a public portfolio company, in a transaction valued at $14.5 billion...
Search

Funds

RTW

FTSE 100

Funds